Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific

The Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC-CCMB), a premier bio-incubator in Hyderabad, has signed an agreement with Thermo Fisher Scientific.

Mac-Chem Products (India) Pvt. Ltd’s Boisar facility Successfully Renews EU-GMP Certification

Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) announced today the successful renewal of its European Union Goods Manufacturing Practices) (EU-GMP certification for its manufacturing facility in Boisar.

IISc launches ‘Longevity India Initiative’ to pioneer ageing research in India

The Indian Institute of Science (IISc) announces the launch of the Longevity India Initiative, a project focused on efforts to extend human 'healthspan' and tackle ageing-related challenges

Takeda's Vedolizumab Secures US FDA Nod To Treat Crohn's Disease

Takeda, a leading pharmaceutical firm, declared that the US Food and Drug Administration (FDA) has granted approval for the subcutaneous administration of Entyvio (vedolizumab) as maintenance therapy in adults with moderately to severely active...

Evotec & Variant Bio Ink Pact To Discover Fibrosis Treatments

Evotec SE and Variant Bio, Inc. have agreed to work together to find the best treatment for fibrosis-related diseases. In organs like the liver and lungs, fibrosis is characterized by a marked and pathogenic accumulation of the tissue matrix and...

Healthcare Needs Tailored Financing and Partnerships: World Bank President

Healthcare requires customized financing, expertise, and collaborations says Ajay Banga, World Bank President. He stated that while and after COVID, money for healthcare rose; but, in order to make healthcare inexpensive and accessible to all...

Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study

Lexaria Bioscience Corp, a proprietary drug delivery technology, declares that a sanction has been received from an independent third-party ethics review board for human pilot study #2 (the "Study"), which examined GLP-1 medications and...

Compass Therapeutics Initiates Phase 1 study of CTX-8371 in Patients

Compass Therapeutics, a biopharmaceutical firm, reported that the intial patient has been dosed in its stage 1 dose-escalation clinical preliminary of CTX-8371, a PD-1 x PD-L1 bispecific neutralizer, in patients with solid tumours. “Dosing the...

Pharma Giant Cipla to Acquire Ivia Beaute For Rs 130 Crore

Cipla, a leading pharmaceutical firm will acquire the beauty care products and individual consideration circulation and marketing business of Ivia Beaute Pvt Ltd, including the brands Astaberry, Ikin and Bhimsaini, on an overall reason for...

Revolutionizing private healthcare with doc-aid – a clinic management solution for private healthcare practitioners

In a significant leap forward for private healthcare practitioners, a revolutionary clinic management solution - Doc-Aid was launched in the city today.

© 2025 India Pharma Outlook. All Rights Reserved.